.. 
.. 
 THE ASPIRIN SUFFERS "THE ASIA SICKNESS"
 
. ..  The crisis in Asian countries keeps on influencing the Bayer's  accounts. In  the first nine months, the German group's  sales, have kept substantially stationary (+0,2%). Once more the stock exchange seems not to appreciate the data, shown by the company even if in line with previsions. All the same, the expectation remains, for the current year, to succeed in keeping unchanged the dividend for shareholders. Nevertheless, to worry both the management and investors is the future that the same company president deems related to the trend of world economic standard.